Investigational Treatment for Hypereosinophilic Syndrome Granted Orphan Drug Status
Orphan Drug designation allows companies a 7-year marketing exclusivity period, should the treatment be approved. Click to View Article
Orphan Drug designation allows companies a 7-year marketing exclusivity period, should the treatment be approved. Click to View Article
How would you like to buy lunch with Will Kassoy, the new president of Omaze? I’m just kidding, but Kassoy has joined a company that makes such things possible. Click to View Article
YieldStreet, the alternative investment platform for retail investors, has agreed to acquire Athena Art Finance from the Carlyle Group and its co-investors for $170M. Click to View Article
Third Pole Therapeutics Announces Inhaled Nitric Oxide Strategic Collaboration with Actelion, a Janssen Pharmaceutical Company of Johnson & Johnson Click to View Article